Sign In / Join

favorite Donate

close

person Sign In / Create Account

Treatment Advances

Our Treatment Advances articles cover treatment option updates, new combinations of treatments, FDA approval news, and more.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

Recent Articles

Understanding Carfilzomib Dosing for Multiple Myeloma image

Understanding Carfilzomib Dosing for Multiple Myeloma

September 03, 2024

Learn about new research on carfilzomib dosing and latest findings on once-weekly Kyprolis and what it may mean for relapsed multiple myeloma patients.

Gene Expression Profile (GEP) SKY92 Test for High-Risk Myeloma

August 26, 2024

Learn how the SKY92 test may help improve treatment outcomes for people with high-risk myeloma.

EHA 2024: Cevostamab for Relapsed and Refractory Multiple Myeloma image

EHA 2024: Cevostamab for Relapsed and Refractory Multiple Myeloma

August 07, 2024

Explore the potential of cevostamab, a new bispecific antibody for multiple myeloma, currently being evaluated in the CAMMA 2 clinical trial.

New Quadruplet Therapy Approved By the FDA for Newly Diagnosed Transplant-Eligible Patients image

New Quadruplet Therapy Approved By the FDA for Newly Diagnosed Transplant-Eligible Patients

August 05, 2024

Great news for newly diagnosed multiple myeloma patients considering stem cell transplant! Learn about the new FDA-approved D-VRd quadruplet therapy.

Promising Results of Linvoseltamab in Relapsed/Refractory Myeloma: LINKER-MM1 Study image

Promising Results of Linvoseltamab in Relapsed/Refractory Myeloma: LINKER-MM1 Study

July 29, 2024

Dr. Suzanne Lentzsch presents promising linvoseltamab updates for myeloma at EHA 2024.

Predicta Biosciences Raises $5.2M to Improve Myeloma Testing and Monitoring image

Predicta Biosciences Raises $5.2M to Improve Myeloma Testing and Monitoring

July 18, 2024

The emerging precision oncology company plans to drastically improve multiple myeloma testing and monitoring through cutting-edge technology and science.

Real-World CAR T Data for Extramedullary Patients image

Real-World CAR T Data for Extramedullary Patients

July 17, 2024

Extramedullary myeloma patients need durable, deep-response-inducing treatment. Could CAR T-cell therapy be the answer?

Smoldering Myeloma: What We Know And Where We’re Going image

Smoldering Myeloma: What We Know And Where We’re Going

July 16, 2024

New research and clincial trial for high risk smoldering myeloma

CHIP and Multiple Myeloma: Impact on Stem Cell Transplant & Survival Rates image

CHIP and Multiple Myeloma: Impact on Stem Cell Transplant & Survival Rates

May 08, 2024

Learn how CHIP gene mutations impact patients undergoing a stem cell transplant. Explore survival rates, treatment options, and the role of IMiDs.

Can AI Detect MGUS Progression With Our Fat Cells? image

Can AI Detect MGUS Progression With Our Fat Cells?

April 30, 2024

Get to know early signs of multiple myeloma progression with AI-driven bone marrow adipocyte analysis. Explore groundbreaking research.

Trending Articles

What Is A Chemo Port?

What Are Neutrophils in Multiple Myeloma?

When Does Smoldering Myeloma Become Active Myeloma?

What is the Impact of Diet on Smoldering and Active Multiple Myeloma?

Why is Multiple Myeloma So Complicated?

Upcoming Events

Patient Panel: Preparing for a SCT: What do I need to bring/know?

Patient Panel: Preparing for a SCT: What do I need to bring/know?

Sep 16 / 14:00 EDT

Talquetamab Side Effect Management

Talquetamab Side Effect Management

Sep 17 / 16:00 EDT

Thriving In The New Normal: Living Your Best Life Despite Myeloma

Thriving In The New Normal: Living Your Best Life Despite Myeloma

Sep 24 / 14:00 EDT

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson

Sanofi

Pfizer

Genentech

Regeneron

Adaptive

Follow Us

Charity Navigator

HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.

Copyright © 2024 HealthTree Foundation. All rights reserved.

Tax ID 45-5354811